The human specific bacterial pathogen Helicobacter pylori (H. pylori) is a Gram-negative microaerophilic bacterium and associated with severe gastric diseases such as peptic ulceration and gastric cancer. Recently, the increasing resistance and the emergence of adverse effects make the usage of antibiotics less effectively. Therefore, development of new antimicrobial agent is required to control H. pylori infection. In the current study, it has been demonstrated the inhibitory effect of β-caryophyllene on H. pylori growth and the protective effect against H. pylori infection as well as antibacterial therapeutic effect. β-caryophyllene inhibited H. pylori growth via downregulation of dnaE, dnaN, holB and gyrA and also down-regulated virulence factors such as CagA, VacA and SecA proteins. β-caryophyllene inhibited expression of several type IV secretion system (T4SS) components including virB2, virB4 and virB8, so that CagA translocation into H. pylori-infected AGS cells was decreased by β-caryophyllene treatment. β-caryophyllene also inhibited VacA toxin entry through down-regulation of type IV secretion system (T5SS). In vivo experiments using Mongolian gerbils demonstrated antibacterial therapeutic effects of β-caryophyllene. After β-caryophyllene administration, immunohistochemistry (IHC) stain using anti-H. pylori antibody showed the antibacterial effect and H&E stain showed the therapeutic effect in treated groups.
Introduction
Helicobacter pylori (H. pylori) is a Gram-negative, spiral-shaped, microaerophilic bacterium that selectively colonizes in human gastric mucosa [1, 2] . By utilizing virulence factors, H. pylori can change the environment and lower the acidity of the stomach, where it impairs the gastric mucosa and alters the gastric acid secretion, thereby disturbing gastric physiology [3] . Compared with uninfected individuals, H. pylori infected individuals have 2-8 fold increased risk of developing gastric cancer [4] [5] [6] . For these reasons, H. pylori has been classified as class I carcinogen by the World Health Organization (WHO) [7] . H. pylori-mediated gastric diseases are mostly due to the effect of its virulence factors. Thus, understanding the biological characteristics and mechanisms of their virulence factors might offer a more comprehensive understanding into the pathogenesis of H. pylori infection.
Cytotoxin-associated protein A (CagA) is a highly immunogenic protein that is encoded by the cag pathogenicity island (PAI). The cagPAI genes also encode components of a type IV secretion system (T4SS), which injects CagA protein into host cells [8] . The T4SS apparatus commonly consists of 11 VirB proteins, encoded by the virB1-B11 genes and VirD4 protein [9, 10] . Once translocation, CagA protein is localizes to the inner surface of the plasma membrane via interactions with phosphatidylserine and sequentially phosphorylated at the Glu-Pro-Ile-Tyr-Ala (EPIYA) sequence repeats by the Src and Abl tyrosine kinases [11] [12] [13] . The phosphorylated CagA also dysregulates the homeostatic signal transduction of gastric epithelial cells leading the loss of cell polarity, apoptosis and proliferation which involved in chronic inflammation and gastric cancer [14] [15] [16] .
Vacuolating cytotoxin A (VacA) protein which is known as a pore-forming secreted toxin, found in almost all H. pylori strains [17] . VacA secretion is regulated by the type Va secretion system (T5aSS) and depends on the Sec machinery for transport through the inner membrane [18] . Secretion system subunit protein A (SecA) is an intracellular ATPase that provides energy necessary for translocation of H. pylori proteins out of the bacterial plasma membrane [18] [19] [20] . Following translocation into the host cells, VacA leads the multiple cellular alterations, including vacuolation and cell death [21] . Cellular vacuolation during H. pylori infection is considered to disrupt protein trafficking pathways and affect a number of cellular functions, such as intracellular degradation of epidermal growth factor and inhibition of antigen presentation in immune cells [22] [23] [24] .
DNA replication is the biological process of copying the DNA in the all living organisms. Initiation of DNA replication occurs after binding of initiator protein DnaA to the AT-rich regions on oriC. DnaA then forms a complex with other nucleoproteins (DnaBC) and ATPs to make the pre-Replicative Complex [25] . DnaB is DNA helicase, progressively unwinds the double stranded DNA in the 5'-3' direction [26, 27] . H. pylori possesses six DNA polymerse III holoenzyme genes. These include two genes for replicase (DnaE and DnaQ), one for clamp (DnaN) and three for clamp loader (DnaX, HolA and HolB) [25] . The termination of DNA replication takes place when the helicase DnaB on the leading strands reaches a Tus protein [26] .
For eradication H. pylori, two or more antibiotics are usually prescribed together with a proton pump inhibitor (PPI) and/or bismuth containing compounds [28] . The triple therapy is the most commonly used firstline regimen for eradication of H. pylori and consists of amoxicillin, clarithromycin and PPI [28] . However, treatment of H. pylori infection is becoming less effective as a result of increasing antibiotic resistance worldwide [29] [30] [31] . In particular, clarithromycin resistance in Asia in 2014 was 32.46% according to a recent review by Ghotaslou et al [29] . These suggesting that development of a new antibiotic agent which alternatively targeted approach to eradicate H. pylori would be needed [32] .
β-caryophyllene is a volatile bicyclic sesquiterpene compound which exists as a mixture of mainly βcaryophyllene and small amounts of α-humulene [33] . It is easily found in the essential oils of many edible plants such as cloves (Eugenia caryophyllata) [34] , oregano (Origanum vulgare) and cinnamon (Cinnamomum spp.) [33, 35, 36] . Recent approval of β-caryophyllene as the food additives and flavoring agent by the Food and Drug Administration in USA (FDA) and the European Food Safety Authority (EFSA) generated the interests among scientific community to explore its additional therapeutic benefits [37, 38] . Numerous reports showed inhibitory effects of β-caryophyllene against bacteria, virus and fungi [39] [40] [41] [42] .
Recently, natural compounds derived from medicinal plants seem to be an important source of antimicrobial agents. Because of the increasing resistance and the emergence of adverse effects, the usage of antibiotics and antibacterial therapeutics is becoming less effective. Therefore, inhibitory effect of β-caryophyllene on H. pylori growth and its inhibitory mechanisms were investigated in this study. Furthermore, it is aimed to discover a new antimicrobial agent to eradicate H. pylori, or identify a new functional health food which can reduce the virulence of H. pylori in infected gastric cells in vitro and in vivo.
Results

Inhibitory effect of β-caryophyllene on the growth and expression of replication genes of H. pylori
As the inhibitory effect of β-caryophyllene on H. pylori was priorly evaluated by screening test using the disc diffusion assay. Clear inhibitory zones were observed around 10, 50 and 100 μg discs and the diameters of the inhibitory zones were 17, 21 and 23 mm, respectively ( Fig 1A) . As the inhibitory effect was confirmed, the minimal inhibitory concentration (MIC) of β-caryophyllene against H. pylori was determined by the broth dilution test. The MIC of β-caryophyllene against H. pylori was determined as 1,000 μg/mL ( Fig 1B) . These results suggest that β-caryophyllene has an inhibitory effect on H. pylori growth.
To elucidate how β-caryophyllene inhibits growth of H. pylori, expressions of replication genes of H. pylori were evaluated. RT-PCR was conducted to confirm the downregulation of the replication genes in βcaryophyllene-treated H. pylori, targeting various genes associated with replication (dnaB, dnaE, dnaN, dnaQ holB and gyrA) of H. pylori. The result confirmed the down-regulation of dnaE, dnaN, holB and gyrA mRNA levels in H. pylori treated with β-caryophyllene ( Fig 1C and 1D ). Therefore, these results indicate that inhibitory mechanism of β-caryophyllene against H. pylori growth is in part associated with interruption of bacterial replication via down-regulation of dnaB, dnaN, holB and gyrA genes.
Suppression of H. pylori-induced apoptosis in gastric epithelial cells by β-caryophyllene
Infection of H. pylori results in deleterious effects on gastric epithelial cells such as disruption of intercellular junction, cytoskeletal rearrangement, vacuolation and induction of apoptosis. Thus it was evaluated whether β-caryophyllene can alleviate the deleterious effects of H. pylori infection on gastric epithelial cells.
When β-caryophyllene was treated to AGS cells without H. pylori infection, the dose higher than 1,000 μg/mL could reduce cell viability (Fig 2A) . Thus, the dose of β-caryophyllene upto 500 μg/mL was used in the following experiments to avoid cytotoxic effect of β-caryophyllene.
It was also investigated whether β-caryophyllene can alleviate apoptotic cell death of gastric epithelial cells induced by H. pylori infection. AGS cells were infected with 200 MOI of H. pylori and treated with βcaryophyllene for 12 h or 24 h, and then cell viability was measured by WST assay. H. pylori infection reduced cell viability of AGS cells to 51.8% in 24 h, but the reduction of cell viability was alleviated upto 87.6% by 500 μg/mL β-caryophyllene treatment ( Fig 2B) . In the Western blot, poly ADP-ribose polymerase (PARP) was cleaved in AGS cells by H. pylori infection indicating induction of apoptosis. The H. pylori-induced PARP cleavage was inhibited by β-caryophyllene treatment ( Fig 2C and 2D ). Furthermore, annexin V-FITC stain was performed to confirm the presence of apoptosis in the same condition. The result analyzed by flowcytometry also showed that apoptosis induced by H. pylori infection was alleviated in AGS cells by β-caryophyllene treatment ( Fig 3A and 3B) . These results collectively suggest that β-caryophyllene inhibited apoptosis and alleviated cell death in AGS cells infected with H. pylori.
Inhibitory effects of β-caryophyllene on the translocation of bacterial CagA and VacA proteins
Cytoskeletal rearrangement and resultant morphological change so-called hummingbird phenotype is a noted outcome appearing after injection of CagA protein into AGS cells and accumulation of cytoplasmic vesicles (vacuolation) is induced by VacA translocation. Furthermore, it was reported that CagA and VacA proteins are closely associated with the H. pylori-induced apoptosis in gastric epithelial cells. AGS cells were infected with H. pylori and at the same time treated with β-caryophyllene and then incubated for 24 h. As a result, H. pylori infection resulted in the morphological changes of AGS cells such as the hummingbird phenotype and vacuolation in the cytosol. However, the morphological changes were alleviated by β-caryophyllene treatment ( Fig 4A) . It was confirmed that both CagA and VacA protein levels were increased by H. pylori infection but the protein levels were decreased in AGS cells after β-caryophyllene treatment ( Fig 4B) . The experiment results were corresponded with the morphological results.
To elucidate the reasons why the translocation of CagA and VacA proteins to AGS cells was inhibited by caryophllene, we investigated the effect of β-caryophyllene on H. pylori directly on the mRNA and protein expressions of CagA and VacA. The mRNA levels of cagA and vacA genes in H. pylori treated with βcaryophyllene were reduced by β-caryophyllene treatment ( Fig 5A and 5B) . The protein levels of CagA and VacA in H. pylori-treated with β-caryophyllene were also downregulated of CagA and VacA in H. pylori (Fig 5C and   5D ). These results, collectively, suggested that β-caryophyllene inhibited the production of CagA and VacA.
Besides, the mRNA and protein levels of SecA in H. pylori, an ATPase responsible for the regulation of T5aSS that secrets VacA protein, were suppressed by β-caryophyllene treatment ( Fig 5) . The mRNA expression levels of virB2, virB4 and virB8, T4SS components in H. pylori, were reduced in a β-caryophyllene dosedependent manner ( Fig 6) . These results suggest that inhibition of CagA and T4SS expression by β-caryophyllene might be in part associated with the decreased translocation of CagA to AGS cells and downregulated SecA as well as VacA might be induced VacA translocation to AGS cells.
Therapeutic effects of β-caryophyllene on Mongolian gerbils infected with H. pylori
Mongolian gerbils were infected with H. pylori to establish an H. pylori-infected animal model. The animal model was treated with or without β-caryophyllene to evaluate the therapeutic effects in vivo. Animals were divided into four groups. "Normal control group" comprised of 7 gerbils that were inoculated with corn oil. "H.
pylori control group" comprised of 8 gerbils that were inoculated with H. pylori (1 × 10 9 cells) and were given no further treatment. Group, "High dose" and group, "Low dose" were inoculated with H. pylori (1 × 10 9 cells) and the administration of β-caryophyllene was started at 2 weeks after initial inoculation. β-caryophyllene was diluted with sterile corn oil at two concentrations. Five hundred μg/g was prepared for high dose group, and one hundred μg/g was prepared for low dose group (S1 Appendix).
Mongolian gerbils in each group were sacrificed at 0 week, 6 weeks, and 12 weeks after beginning of the pylori infection in gastric epithelium of the gerbils (Fig 7 and 8) . H. pylori were also detected in the βcaryophyllene-treated groups at 0 week, but the positive signals were decreased over times after β-caryophyllene treatment suggesting that both low dose (100 μg/g) and high dose (500 μg/g) of β-caryophyllene significantly reduced the degree of infection by H. pylori (Fig 7 and 8) . These results collectively indicate the therapeutic effects of β-caryophyllene on Mongolian gerbils infected with H. pylori.
Inhibitory effects of β-caryophyllene on the H. pylori-induced inflammation
The gastric tissue sections were also stained with hematoxylin & eosin (H&E) and observed with microscope to evaluate the inflammation in the tissue. In the H. pylori control group, abnormally disrupted shape of gastric epithelium was observed at 12 weeks indicating that inflammation was occurred by H. pylori infection.
However, the gastric epithelium was almost undamaged in β-caryophyllene-treated groups suggesting that the inflammation induced by H. pylori was alleviated by β-caryophyllene treatment ( Fig 9A) .
Blood was collected from the left atrium of all the gerbils during sacrifice. In the H. pylori control group, number of total leukocytes was dramatically increased since 6 weeks in comparison to the normal control group indicating leukocytosis. Although, slight increases of total leukocytes were also observed in low dose (100 μg/g) or high dose (500 μg/g) of β-caryophyllene treated groups, β-caryophyllene treatment alleviated leukocytosis induced by H. pylori infection. Similar pattern was also observed in the number of lymphocytes and monocytes.
Lymphocytes and monocytes were also increased in the blood of gerbils by H. pylori infection but the increases of lymphocytes and monocytes were alleviated by treatment of β-caryophyllene. However, no significant increase of neutrophils was observed after H. pylori infection ( Fig 9B) .
Cytotoxicity of β-caryophyllene in vivo
Chemicals may have toxicity thus can damage the organs such as liver and kidneys during the medication.
Weight of the Mongolian gerbils was measured periodically during the experiment. However, no significant differences were observed among the groups (S1 Table) . Hepatotoxicity and nephrotoxicity was evaluated in the gerbils exposed to β-caryophyllene. The hepatic and renal tissue sections of the gerbils were stained with hematoxylin & eosin and observed by microscope. In the results, histopathological lesions were not detected in the low dose (100 μg/g) of β-caryophyllene-treated group. In the high dose (500 μg/g) of β-caryophyllene-treated group, however, hemorrhagic lesions containing red blood cells were observed in both hepatic and renal tissues ( Fig 10) . These results suggest that low dose (100 μg/g) of β-caryophyllene has no liver toxicity and nephrotoxicity.
IV. DISCUSSION
Development of new antimicrobial agents with fewer disadvantages is necessary for eradication of H. pylori.
Β-caryophyllene is one of the natural compounds which easily found in the essential oils of many plants [34] [35] [36] .
According to several reports, β-caryophyllene has antibacterial effect on cariogenic bacteria and food-spoilage bacteria [39] [40] [41] . This study demonstrated the inhibitory effect of β-caryophyllene on H. pylori growth and the protective effect against H. pylori infection as well as antibacterial therapeutic effect. The aim of this study was to discover the new antimicrobial agent from nature which may inhibit the H. pylori infection, thus this study aimed to investigate on the effect of β-caryophyllene as one of the natural compound which possess multiple pharmacological properties [33] .
In this study, inhibitory effect of β-caryophyllene on H. pylori was firstly evaluated by disc diffusion assay ( Fig 1A) . Then, it was observed that the MIC of β-caryophyllene against H. pylori was 1,000 μg/mL in the broth dilution test ( Fig 1B) . Expressions of replication genes of H. pylori were evaluated to elucidate how βcaryophyllene inhibits the growth of H. pylori. β-caryophyllene treatment decreased the mRNA expression levels of dnaE, dnaN, holB and gyrA genes ( Fig 1C and 1D) . DnaE is the catalytic α subunit of DNA polymerase III. It has been reported that the mutant dnaN was unable to support E. coli growth [43] . Song et al. have shown that E. coli strains bearing chromosomal knockout of holB gene was not viable [44] . These studies demonstrated that the DnaE, DnaN and HolB are necessary for cell growth, thus they are indispensable. DNA gyrase is pivotal for the process of bacterial replication, so that it has received the most attention for developing antibiotics such as novobiocin (the ATP site inhibitor) and flioroquinones (the catalytic site inhibitor) [45, 46] . Therefore, interruption of bacterial replication via down-regulation of dnaE, dnaN, holB and gyrA genes by β-caryophyllene may explain the inhibitory mechanism of β-caryophyllene against H. pylori growth.
In this study, it was evaluated whether β-caryophyllene can alleviate the deleterious effects of H. pylori infection on gastric epithelial cells. β-caryophyllene showed no cytotoxic effect on AGS cells upto 500 μg/mL (Fig 2A) . Since the apoptotic cell death is closely related to the gastric cancer development, the effect of βcaryophyllene treatment on H. pylori-induced apoptotic cell death was assessed by performing cell viability test, Western blotting and Annexin V staining [47, 48] . The results revealed that apoptosis induced by H. pylori infection was alleviated in AGS cells by β-caryophyllene treatment (Fig 2B, 2C, 2D, 3A and 3B ).
Furthermore, β-caryophyllene treatment diminished the hummingbird phenotype and vacuolation on H.
pylori-infected AGS cells dose dependently ( Fig 4A) and also inhibited CagA and VacA translocation into the H. pylori-infected AGS cells ( Fig 4B) . It was due to the reduction of the CagA, VacA and SecA as well as that of several T4SS components including virB2, virB4 and virB8 expression by β-caryophyllene treatment (Fig 5 and   6 ). Both CagA and VacA proteins disrupt intracellular signaling in host cells that lead to uncontrolled growth of the cells and inflammatory responses [1, 2, 49, 50]. Therefore, the results imply that the decrease of CagA and VacA by β-caryophyllene treatment will alleviate the tumorigenesis and inflammation induced by H. pylori in gastric mucosa. Collectively, these in vitro data provides evidence supporting that β-caryophyllene may helpful to attenuate the deleterious effects such as hummingbird phenotype, vacuolation and apoptotic cell death induced by H. pylori infection.
The in vivo experiments in this study demonstrated the therapeutic effects of β-caryophyllene. IHC staining data indicated that β-caryophyllene administration relieves the infection of H. pylori (Fig 7 and 8) and H&E staining data showed that β-caryophyllene treatment diminishes inflammation in H. pylori-infected stomach tissues (Fig 9) . The reason why inflammatory signs are decreased in β-caryophyllene-treated groups is owing to the colonized H. pylori might be eradicated by β-caryophyllene administration. In long-term in vivo study, In the hematological study, the numbers of total leukocytes in H. pylori control group were vertically increased at 6 weeks and maintained highly at 12 weeks. The numbers of total leukocytes in β-caryophyllenetreated groups, however, were gradually increased after β-caryophyllene administration ( Fig 9B) . Detailed comparison of hematological changes between β-caryophyllene-untreated group and β-caryophyllene-treated groups also showed that the treatment of β-caryophyllene alleviates H. pylori infection. Because neutrophils actively resist to bacterial infection, increased-neutrophil count is commonly found in bacterial infection.
However, elevated numbers of neutrophils were relieved by β-caryophyllene administration. This finding implies that bacterial infection is dwindled or bacterial pathogenesis is hindered. In addition to neutrophils, the increased number of lymphocytes and monocytes were lessened at 6, 12 weeks after β-caryophyllene administration.
Contrary to human leukocytes, the composition ratio of lymphocytes in total leukocytes is over 60% in Mongolian gerbils [52, 53] . Resulting from the ratio, total changes of leukocytes may be mostly affected by the changes of lymphocytes in Mongolian gerbils. These data correspond with preceded histological data and this certainly supports the therapeutic effect of β-caryophyllene on H. pylori infection. Meanwhile, there may be controversial about neutrophil count data because of the sudden fluctuation in high dose group at 12 weeks. It is speculated that daily medication with high dose of β-caryophyllene may lead the chemical toxicity.
In vivo toxicological studies of β-caryophyllene have been revealed that it has a very large therapeutic window, with an oral LD 50 of more than 5,000 μg/g in rats and mice [54, 55] . On the other hand, the toxicological effects of β-caryophyllene on Mongolian gerbil are not reported. In this regard, the two doses (100, 500 μg/g) of β-caryophyllene which are less than 1/10 of LD 50 were chosen to assess the toxicological effects. In this study, mortality or other signs of toxicity were not detected in the low dose (100 μg/g) of β-caryophyllene-treated group.
However, mild hepatotoxicity and nephrotoxicity were detected in the high dose (500 μg/g) group. This result conformed with neutrophil count which indicates the damage of organs.
Further studies are required to fully elucidate about the anti-inflammatory and anti-apoptotic mechanism of β-caryophyllene against H. pylori. Previous study from Tambe et al. suggested that β-caryophyllene has gastric cytoprotective effect [56] . Thus it would be intriguing to study about the anti-inflammatory and anti-apoptotic mechanism of β-caryophyllene during H. pylori infection. Along with these mechanism study, the oral LD 50 of βcaryophyllene in Mongolian gerbil seems to be necessary to establish. 
Materials & Methods
Bacterial culture and determination of antibacterial activity
Mammalian cell culture
AGS gastric adenocarcinoma cells (ATCC CRL-1739) were cultured in DMEM medium (BRL Life
Technologies) supplemented with 10% fetal bovine serum (BRL Life Technologies) and streptomycin-penicillin (100 μg/mL and 100 IU/mL, BRL Life Technologies). Cells were infected with H. pylori as a concentration of 200 multiplicity of infection (MOI) without addition of antimicrobial agents in media and then treated with βcaryophyllene (250 and 500 μg/mL). For normal control, the equivalent amount of ethanol was administrated to culture media. In the experimental groups, the results were compared with normal control group and each experiment were repeated over three times to confirm data.
RT-PCR
H. pylori ATCC 49503 strain was grown in Mueller-Hinton broth (Becton-Dickinson) for 72 h. Cultured H. pylori was washed twice with phosphate-buffered saline (PBS) and total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, USA) as described in the manufacturer's instructions. cDNA was synthesized by reverse transcription with random hexamer (Invitrogen) and Moloney murine leukemia virus reversetranscriptase (MMLV-RT, Invitrogen). Subsequent PCR amplification performed in a thermocycler using specific primers. The PCR primer sequences used in this study are listed in Table 1 [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] . Gel images have been captured and analyzed using the Quantity One system (Bio-Rad, Hercules, CA, USA).
Western blotting
Bacteria and AGS cells were lysed with radio immunoprecipitation assay (RIPA) lysis buffer (Millipore, Billerica, MA, USA) containing a protease inhibitor cocktail (Calbiochem, San Diego, CA, USA). The cell lysates were incubated on ice for 30 min. In order to lyse the bacterial cells completely, the mixture was sonicated for 2 minutes with 10 second intervals (Sonicator XL-2020, Heat Systems Ultrasonics, Pittsburgh, PA, USA). The cell lysates were then centrifuged at 13,000 g for 10 min at 4°C and the supernatants were collected. Protein concentrations were determined based on Lowry method and quantified using NanoQuant spectrophotometer Antibodies to detect CagA, VacA and -actin were purchased from Santa Cruz Biotechnology (Dallas, TX, USA) and polyclonal antibody against whole H. pylori (ATCC 49503) and SecA were produced as previously described [20, 66] . Antibodies to detect PARP was purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-H.
pylori polyclonal antibody and -actin were used as an internal control for bacteria and mammalian cell proteins.
WST cell viability assay using EZ-Cytox
AGS cells (1×10 4 per well) were plated in 96-well plates. After 24 h, cells were treated with various concentrations of β-caryophyllene. The cells were then incubated for 24 h and subjected to water soluble tetrazolium salt (WST) assay by using EZ-Cytox cell viability assay kit according to manufacturer's instruction.
Ten μL of WST solution was added to the cultured media and incubated for 2 h in the CO 2 incubator. The absorbance was measured at 450 nm by spectrophotometer.
Annexin V and PI staining
Annexin V and PI staining was performed by using Annexin V-FITC Apoptosis Detection Kit I (Becton-Dickinson) according to the manufacturer's instruction. The cultured cells were detached with 0.25% trypsin-EDTA, washed twice with cold PBS, and centrifuged at 3000 rpm for 5 mins. The cells were resuspended in 500 μL of 1X binding buffer at a concentration of 5 × 10 5 cells/mL and 5 μL of Annexin V-FITC and 5 μL of PI were added to the cell suspension. The mixture was incubated for 10 minutes at 37°C in the dark and analyzed by FACS Caliber flow cytometry (Becton-Dickinson).
Animal and experimental design
Inbred specific pathogen free (SPF) 5 week-old, male and female Mongolian gerbils for mating were purchased from Central Lab Animals, South Korea. Gerbils used in this study were obtained from 10 breeding cages bred inhouse. Animals at the age of 6-7 week-old (n=31) were gathered and challenged orogastrically threetimes over five consecutive days with approximately 1 × 10 9 cells of viable H. pylori. β-caryophyllene was orogastrically administrated every day for 12 weeks. All gerbils were sacrificed using CO 2 euthanasia at different times post-administration (0, 6, 12 weeks). The stomach was excised, opened along the greater curvature. One half was used for a culture study (reisolation) and extraction of RNA while the other was used for immunohistochemical and histopathological analyses. The blood samples were taken from all sacrificed gerbils for hematological examination. 
Assessment of histopathology
Paraffin embedded longitudinal sections of antrum and corpus were stained with hematoxylin & eosin (H&E) and evaluated. It was graded for gastritis and mucosal changes and analyzed by a double blind test according to the grading scheme for rodents [51, 67] . To determine toxicity of β-caryophyllene in vivo, gerbils were orogastrically administrated β-caryophyllene every day for 6 weeks or 12 weeks. The concentrations of βcaryophyllene were either a "low dose" (100 μg/g) or "high dose" (500 μg/g). A total of 7 Mongolian gerbils were sacrificed at 6 and 12 weeks and their renal and hepatic tissues were excised for histopathologic analysis.
Statistical analysis
Data in the bar graphs are presented as mean ± standard error of mean (SEM). All the statistical analyses were performed using GraphPad Prism 5.02 software (GraphPad Software, San Diego, CA, USA). All the data were analyzed by unpaired Student's t-test and P < 0.05 was considered to be statistically significant (*P < 0.05, **P < 0.01 and ***P < 0.001). Mongolian gerbils were orogastrically administrated β-caryophyllene or corn oil every day for 6 weeks or 12 weeks. A total of 10 Mongolian gerbils were sacrificed at 6 and 12 weeks and their renal and hepatic tissues were excised for histopathologic analysis. Low dose (100 μg/g) of β-caryophyllene has no hepatotoxicity and nephrotoxicity. However, high dose (500 μg/g) of β-caryophyllene has mild hepatotoxicity and nephrotoxicity.
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